Remove Angina Remove Circulation Remove Heart Transplant
article thumbnail

Abstract 4144084: Enhanced External Counterpulsation as a Novel Treatment for Heart Transplant Candidates with Ischemic Heart Failure with Reduced Ejection Fraction

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page A4144084-A4144084, November 12, 2024. It is primarily indicated for refractory angina that is not amenable to PCI or CABG with the opinion of a cardiologist. It is primarily indicated for refractory angina that is not amenable to PCI or CABG with the opinion of a cardiologist.

article thumbnail

Highlights of ACC 2024

Cardiology Update

The Impella CP is a catheter-based, axial flow pump that pumps blood directly from the left ventricle into the circulation. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes.

Angina 52